Psoralens are tricyclic furocoumarins with potent photosensitizing properties in the skin and are now widely u sed in the treatment of several dermatologic diseases_ In this study the effect of 3 different p s oralens 8-methoxypsoralen (8-MOP), 4,5 ',8-trime thylpsorale n (TMP) and isopsOl'alen on hepatic microsomal drug-metabolizing e nzymes and cytochrome P-450 has been assessed in mice and rats. 8-MOP administered orally to CD-! mice daily for 6 days caused 2-3 fold increases in hepatic al'yl hYW'ocarbon hydroxylase (AHH), ethylmorphine N-demethylase and cytochrome P-450. The absorbance maximum of the induced cytochrome was at 450 nm. Aniline hydroxylase activity was unchanged. Chronic administration of 8-MOP to hairless mice caused significant e nhancement of h epatic e thylmorphine N-d e m ethylase and cytochrome P-450 but had no effect on AHH; whereas chronically administer e d TMP had no significant effect on any of these para meters. Isopsoralen a nd TMP administe r ed orally to CD-! mice d a ily for 6 days had no effect on any of these liver enzymes or on h epatic P-450. 8-MOP administered daily for 6 days to rats caused a greater than 4-fold enhancement of AHH and greater than 2-fold enhancem ent of ethylmorphine Ndemethylase and cytochrome P-450. These studies indicate that orally administe r e d 8-MOP induces hepatic drug-metabolizing enzymes and cytochl"ome P -450 to a lesser extent than do the barbituates and suggest that this drug could influence the rate of biotransformation of concomitantly administered w'ugs in patients und e rgoing PUV A therapy.
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The psorale ns a r e naturally occurring furocoumru"in compounds tha t are used clinically in th e treatmen t of selected d ermatologic diseases including vitiligo [1] , psoriasis [2, 3] , a nd mycosis fungoides [4] [5] [6] . D espite t heir widespread u every li ttle is Imown concerning the m etabolism of these compounds. Mandula, Pathak, a nd Dude k demonstra ted that one of t h e psorale ns, trime thylpsorale n (TMP) , is metabolized to 4,8-diManusc ript, received October 23, 1981 ; accepted fo r publication Febru ary 22, 1982. This work was supported by U.S. P ublic Health Service Grants . olite is a lso found in t h e mine of huma n subjects [7] .
Further studies h ave sh own t h at TMP is converted into at least 3 separate m etabolites by mouse liver microsomes in vitro [8] . This metabolic biotransformation of TMP is dep e nde n t on NADPH a nd fulfills the co-factor r equire m en ts for a mixedfunction oxidase reaction. An important ch aracteristic of the mixed-function oxidase system is t he abili ty of m a n y differ e n t ch emicals including drugs to induce its m etabolic activity in vru'ious t issues including liver a nd s kin [9, 10] . No studies have rigorous ly evaluated t h e possible indu ction effects of variou p sor ale ns on hepatic and cutaneous drug m etabolis m a nd cytochrome P-450. Mandula, Path ak, and Dudek did show th at a s ingle acute dose of psoralens h ad sligh t induction effects in t h e liver but no evaluatio n of t h e effect of chronic a dministration of these compounds o n t h e h eme-protein cytoch.rome P-450 was performed .
In the study r eported h e re we assessed the effects of systemically administered psorale n compounds on t he in vitro h ep at.ic microsomal m etabo lism of model substrates a nd on cytocluome P-450. W e furth e r compa red t h e induction effects of psora lens to t hose of model inducers su ch as phe noba rbital and 3-m ethylchola nt hl'e ne in mice a nd rats. Finally, t h e effect of topically a pplied psorale ns o n cu ta neous drug m etabolism was also evaluated .
MATERIALS AND METHODS

Mat eriaLs
4,5',8-trimethylpsoralen (TMP) and 8-methoxypsoralen (8-MOP) were gifts from the Paul B. Elder Co mpany (Bryan, Ohio). lsopsoralen was isolated from Psoralea co rylifolia (leguminosae) and purified and chanlcterized by high pressure liquid chromatography, NMR and mass spec troscopy in ow' laboratories. All of the psoralens were repeatedly recrystallized in hot methanol prior to use in order to maximize purity. T his was confir med by thin-laye r cl1l"omatography, NADPH, 3-methylcholanthrene, and benzo (a) pyre ne were obtained from Sigma Chemical Co mpany (St. Louis, MO) . All other chemicals were of the highest grade commercially available.
Treatm ent of Animals
Male mice (strain CD-I) fro m the Charles River Breeding Laboratories weighing 25-30 gm were treated daily fo r 6 days by oral administration of 8-MOP, TMP or iso psoralen at a do e of 0.8 mg/ kg/ day. Since all of these drugs ru'e highly water insoluble (50 mg/ L) they were suspend ed in 10% gum acacia (USP) and administered p.O. by stomach tube. Co ntrols received the vehicle alone. In other experiments the effects of orally administered 8-MOP were co mpared with those of typical inducers of drug metabolism such as phenobru'bital (75 mg/ kg/ day X 3 in saline) and 3-methylcholan threne (40 mg/ kg/ day X 3 in corn oil) in the CD-l mice. The effects of chronically administered 8-MOP (1.2 mg/ kg/ day) S days per wee k for 6 mo were also evalu ated using hairless mi ce (Strain SKH:hr-l obtained from Dr. G Mann, GenetIcs Division, Skin and Ca ncer Hospital, T emple University, P hiladelphia, Pennsylvania) .
T he effects of orally administered 8-MOP were also assessed in male Sprague-Dawley rats (Ho l tzm~U1 , Madiso n Wisco nsin). 8-MOP was suspended in corn oil by so nication and administered orally at a dose of 0.8 mg/kg/day for 6 days. On day 7, the animals were sacrifi ced. In other studies the effect.s of topical application of 8-MOP and 3-MC 011 cutaneous AHH was compared in rat skin. The nuchal region of the animals was shaved with clippers and treated with topicaUy applied 8-MOP (50 mg/ kg in acetone) or 3-MC (50 mg/kg) once daily for 3 days and the animals sacrified on day 4.
Preparation of Microsomes
Twenty-four hours after the last treatment the an imals were killed by decapitation and washed hepatic microsomes were prepared as desc ribed previously [12) . Whol e skin homoge na tes were prepared by techniques routinely used in these laboratories [13) .
Enzyme Assays
Cytochrome P -450 concentrations in hepatic microsomes were a nalyzed from the dithionite plus carbo n monoxide minus dithionite difference spectrum [14] employing a DW-2a spectrophotometer. Baseline correction was obtained using a Midan Microprocessor. The molar ex tin ction coeffici ent of 91,000 was used for the absorbance cha nge between 450-490 nm to determine the cytochrome P -450 concentrations. Ethylmorpliine N-demethylase activity was determined as described by Alvares and Mannering [15] . The forma ldeh yde formed was estimated colorimetrically as described by Nash [16] . Aniline h yd roxylase was assayed by measuring the formation ofp-aminophenol by the phenol indophenol method ofImai, Ito, and Sato [17] . Aryl hydrocarbon hydroxylase activity was determined by a modification of the method of Nebert and Gelboin [18] as described previous ly [12] . The quantitation of phe nolic BP metabolites was based on comparison of fluore scence to a standard of 3-hydroxybenzo(a)pyrene (3-0HBP). Protein was estimated according to Lowry et a l [19] . us ing bovine serum albumin as a reference standard.
Spectral Binding Studies
Microsomal suspensions containing microsomes equivalent to 100 mg of liver, wet we ight, per ml of 0.1 M K2HPO.,-KH2PO., buffer, pH 7.4 , were used. Spectral changes caused by the add it ion of 8-MOP to liver microsomes were carried out as described by Schenkman, RemmeI', and Estabrook [20] .
RESULTS
Comparative Effects of 3 Different Psoralens on Hepatic Drug M etabolism and Cytochrome P-450 in Mice
As shown in Table I , oral administration of isopsoralen and 8-MOP both caused significant increases in hepatic microsomal protein while TMP had no such effect. 8-MOP also caused a 3-fold increase in AHH activity, a 2-fold increase in ethylmorphine N -demethylase activity and a 50% increase in cytoch. rome P-450. The absorbance maximum of the 8-MOP-induced hepatic microsomal heme-protein was at 450 nm (Fig 1) . In contrast, isopsoralen and TMP evoked no statistically significant increases in any of these latter measurements.
Comparative Effect of 8-MOP ~ith Other Typical Inducers of Hepatic Drug-metabolizing E..nzymes
Inducers of cytochrome P-450 and hepatic drug-metabolizing enzymes can be divided into at least 2 broad categories [10] . One group, of which phenobarbital is a typical example, enVol. 79, No.3 hances the biotransformation of a large number of substrates and increases a microsomal heme-protein with an absorbance maximum at 450 nm. The second group, of which 3-methylcholanthrene is a typical example, enhances the metabolism of a much smaller number of substrates and induces a microsomal heme-protein known as P-448 or P,-450 [19] that is spectrally and catalytically distinct from P-450. The enzyme induction effect of 8-MOP was compared to that of phenobarbital and 3-methylcholanthrene in an effort to identify the category of inducer to which it belongs.
As shown in Table I , both 8-MOP and phenobarbital caused significant increases in hepatic microsomal protein content and in AHH activity while 3-MC had no such effect. Both phenobarbital and 3-MC significantly enhanced aniline hydroxylase activity while 8-MOP did not. Phenobarbital and 8-MOP each caused significant increases in ethylmorphine N-demethylase activity and in the levels of cytochrome P-450. These data indicate that 8-MOP is a phenobarbital type of inducer in CD-1 mouse liver. In further studies the spectral characteristics of the cytochrome P-450 induced by 8-MOP were compared with those evoked by phenobarbital and 3-MC. The CO-difference spectra of liver microsomes from control mice and from mice treated with 8-MOP, phenobarbital and 3-MC are shown in Fig  1. As would be expected liver microsomes from controls and phenobarbital-treated animals showed an absorption maximum at 450 nm, whereas microsomes from 3-MC treated animals showed an absorption maximum at 448 nm. Liver microsomes isolated from 8-MOP treated mice demonstrated a peak absorbance at 450 nm. These data indicate that 8-MOP is a phenobarbital type of heme-protein inducer though its potency ., 
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203 as a n inducer appears to be considerably less tha n t hat of the barbiturate.
E ffects of Chronic Adm in istration of 8-MOP and TMP on H epatic Drug Metabo lism in Hairless Mice
logic t herapy because of t heir ability to function as photosensitizers and as inhibitors of DNA synthesis. In the presence of longwave ultraviolet radiation (UV -A or 320-400 nm) the photoactivated psoralens form covalent bonds with pyrimidine
As shown in T able II, oral administration of 8-MOP for 6 m o evoked a significant incr ease in ethylmorphine N-dem ethylase activity and in cytochr ome P-450 levels but had not effect on AHH activity. Chronically administered T M P caused no detectable changes in a ny of these m easurem ents.
E ffect of 8-MOP on Hepatic Drug Metabolism in SpragueDawley Rats
T hese studi es were carried ou t in Sprague-Dawley rats to furt her characterize th e enzyme induction effects of 8-MOP in a nother widely studied animal species. As shown in Table III , 8-MOP caused significan t increases in liver microsomal AHH a nd ethylmorphine N-dem ethylase activities a nd in cytociu'om e P-450 levels bu t had no effect on microsom al protein con tent, or on a niline hydroxylase activity. CO-di ffer ence s pectra of hepatic microsomes prepar ed fTom these animals also confirmed th at 8-M OP induced a heme-protein with a n a bsorba nce maximu m at 450 nm. In addition, t he ethyl isocyanide difference spectra of microsomes from control a nd 8-M OP treated rats showed 455:430 peak ratios of 0.64 a nd 0.66 respectively (Table  III) . T his is also consisten t with a phenobarbital type of induction response.
Binding Spectrum, of 8-MOP to Control Liver Microsomes
Compounds interact with hepatic microsomal suspensions to give a Type I differe nce spectrum, characterized by a peak at abou t 385 nm a nd a trough at about 420 nm, or a Type II diffe rence spectrum, characterized by a peak at a bout 430 nm a nd a trough at abou t 390 nm . As shown in F ig 2, addition of 8-MOP resul ted in a Type I difference s pectrum which is identical to that of hexabaJ·bital. T his finding ind icates that 8-MOP interacts with liver microsom es sim ilal' to oth er Type I compounds.
E ffect of Topical Application of 8-MOP and 3-MC on AHH, a Drug-m etaboliz in.g E n zy m e in Rat Sllin
In these studies an effor t was m ade to determine whether to pically applied 8-MOP had any indu ction effect on cu taneous drug metabolism . The activity of the car cinogen-metabolizing enzyme, AHH, was assessed as shown in Table IV . 3-M e caused a 20-fo ld enhancem ent of t he skin enzy me wh ereas 8-MOP had no ind uction effect whatsoever. T his is of interest since it is consistent wit h our data in liver indicating t hat 8-MOP is an inducer of the barbiturate type which characteristically has little or no induction effect upon drug metabolizing enzyme activity in the skin. DISCUSSION Psora lens (B-methoxypsoralen and psoralen) have been used since an tiqui ty in the tr eatment of t he amela notic skin disease know n as vitiligo [22] a nd more recently 8-M OP has been used in the tr eatment of psoriasis [3] , mycosis fungoides [4J and seve ral other skin disorders. T he linearly a nllulated ph otoreactive psoralens are furocoumarin compounds useful in dermato- b S ignifi ca ntly differ ent from co nt rol (p < 0.05) .
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1.23 ± 0.14" 0.0 ± 0.05 bases in DNA [23, 24) . These light-activated cycloaddition products are formed between the 3,4, or 4' ,5', position of the psoralen molecule and the 5,6 position of pyrimidine bases [24, 26) . Crosslinks between opposite strands of DNA are subsequently formed which in turn may account for the known ability of psoralens to inhibit DNA synthesis and replication. Previous studies have also shown that topically applied or orally administered psoralens in combination with UV -A can form cycloaddition products and crosslinks with DNA of skin cells in experimental animals and in humans receiving photo chemotherapy with psoralens [27) . Despite the increasing clinical use of the psoralens in treating a variety of dermatologic diseases, relatively little is known concerning the absorption, distribution and metabolism of these compounds either in experimental animals or in humans. Orally administered psoralens are almost totally absorbed in the gastrointestinal tract and less than 5% can be detected in the feces [29, 30] . Within 12 hr more than 90% of an orally administered dose of 8-methoxypsoralen can be found in the urine primarily as glucuronides or as hydroxylated moieties. Maximum blood levels of these drugs occur 2-3 hours following oral administration after which they appear to be rapidly excreted in the urine.
Little is known concerning the metabolism of psoralens by the liver or other tissues. Mandula, Pathak, and Dudek have shown that TMP is apparently metabolized in part to 4,8-dimethyl, 5' -carboxy-psoralen (DMeCP), a nonphotosensitizing metabolite which can be detected in the urine of mice and of humans to whom TMP is administered orally [7) . Recent studies have shown that microsomes obtained from untJ'eated CD-1 mice are capable of metabolizing TMP to DMeCP as well as to selected other metabolites in vitro [8) . These studies also showed that this reaction required NADPH and oxygen for optimal catalytic activity. Thus TMP appears to be metabolized at least in part by the hepatic microsomal cytochrome P-450-dependent mixed-function oxidase system. 8-MOP, on the other hand, does not appear to be appreciably metabolized ~n mice or in humans although at least 4 metabolites are observed in the urine of mice and of human subjects receiving oral 8-MOP [31) . Careful analysis of urine from animals and humans receiving 8-MOP showed that only a small percentage «5%) is excreted as the unmetabolized parent compound. Kolis et al studied the metabolism of HC-8-MOP in dogs [32) . They isolated several metabolites from the urine including 7 -hydroxy-8-methoxy-2-oxo-2-H-1 benzopyran-6-acetic acid, a,7-dihydroxy-8-methoxy-2-oxo-2H-1-benzopyran-6 acetic acid and (Z)-3-(6-hydroxy-7-methoxybenzofuran-5-yl)-2 propenoic acid.
We attempted all manner of variation of standard methods of in vitro incubation of 8-MOP with micro somes from untreated CD-l mice and coulCl find no evidence of metabolite formation. In other studies we have attempted without success to d~monstrat~ in vitro metabolism of 8-MOP by microsomal fractlOns obtamed from rats and mice (either untreated or treate~ with p~enobarbital, 3-methylcholanthrene, or the polychlormated blphenyls (PCBs) , unpublished observations). A major limiting factor in these in vitro assay systems is the very poor water solubility (approximately 50 mg/L) of the 8-MOP which may inhibit its ability to penetrate the microsomal membranes. Data presented in this paper indicate that treatment of mice and rats with psoralens can cause enhancement of hepatic microsomal drug metabolism and the heme-protein cytochrome P-450. Of the 3 psoralens studied 8-MOP was the only one which had consistently significant effects of drug-metabolizing enzymes and cytochrome P-450. Thus, short-term (daily for 6 days) 8-MOP administration caused significant increases in microsomal protein concentration, AHH and ethylmorphine Ndemethylase activities and cytochrome P-450 concentrations in mouse liver. Chronic administration (5x weekly for 6 mol of 8-MOP also caused significant increases in ethylmorphine Ndemethylase and cytochrome P-450. Short-term administration Vol. 79, No.3 of 8-MOP to Sprague-DaWley rats caused significant increases in hepatic microsomal AHH, ethylmorphine N-demethylase and cytochrome P-450 while TMP had no effect upon a ny of these measurements.
Spectral studies of the 8-MOP-induced heme-protein indicated that the absorbance maximum was at 450 nm, similar to that of control or phenobarbital-treated a nimals. Ethyl isocyanide difference spectra also showed that microsomes prepared from 8-MOP treated animals demonstrated a 455:430 peak ratio similar to that of control or phenobarbital-treated animals. The addition of 8-MOP to liver microsomes resulted in a Type I difference spectrum. These findings, in aggregate, suggest that 8-MOP may be a substrate for liver microsomes although we were unable to verify this possibility in the studies described here.
Skin application of 8-MOP to neonatal rats had no effect upon cutaneous AHH activity an enzyme which in this tissue normally increases in activity following treatment with polycyclic aromatic hydrocarbon carcinogens such as 3-MC. Thus, 8-MOP does not appear to influence this microsomal enzyme system in the skin.
In summary, our studies indicate that 8-MOP is a moderately potent inducer of hepatic microsomal drug-metabolizing enzymes and cytochrome P-450 and that the induction response to this drug is analagous to that which occurs in animals treated with barbiturates.
Our data indicate that administration of 8-MOP to patients undergoing PUV A therapy may alter rates of hepatic metabolism of concomitantly administered drugs. While the enzyme induction effect of 8-MOP is qualitatively similar to that evoked by the barbiturates, it is quantitatively much less effective in this regard. These findings suggest that the interaction of psoralens with the hepatic metabolism of other drugs is likely to pose a less serious problem than that which has been attributed to the barbiturates.
